论文部分内容阅读
目的:观察艾迪注射液对肿瘤化疗患者生活质量的影响。方法:采用随机方法将40例癌症患者分为艾迪加化疗组(艾迪组)和单纯化疗组(化疗组)。对完成2个以上疗程的患者进行疗效、生活质量、毒副反应的比较。结果;有效率:艾迪组与化疗组比较无明显差异(P>0.05):KPS评分:艾迪组与化疗组比较有显著性差异(P<0.05):胃肠道反应、白细胞下降、血小板下降的发生率:艾迪组均低于化疗组,艾迪组与化疗组比较均有显著性差异(P<0.05)。结论艾迪注射液联合化疗能降低化疗毒副反应,提高疗效.改善晚期恶性肿瘤化疗患者的生活质量。
Objective: To observe the influence of Aidi Injection on quality of life in patients with tumor chemotherapy. Methods: Forty cancer patients were randomly divided into two groups: Aidi plus chemotherapy group (Aidi group) and chemotherapy alone group (Chemotherapy group). The completion of more than two courses of treatment of patients, the quality of life, toxicity and side effects comparison. Results: Efficacy: There was no significant difference between the Aidi group and the chemotherapy group (P> 0.05). KPS score: There was a significant difference between the Aidi group and the chemotherapy group (P <0.05): gastrointestinal reaction, leukopenia, The incidence of decline: the Aidi group were lower than the chemotherapy group, Aidi group and chemotherapy group were significantly different (P <0.05). Conclusion Aidi injection combined with chemotherapy can reduce the side effects of chemotherapy, improve the curative effect, and improve the quality of life of advanced malignant tumor chemotherapy patients.